1. ECMO support for right main bronchial disruption in multiple trauma patient with brain injury—a case report and literature review. (July 2015) Authors: Zhou, R; Liu, B; Lin, K; Wang, R; Qin, Z; Liao, R; Qiu, Y Journal: Perfusion Issue: Volume 30:Number 5(2015) Page Start: 403 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Evaluation of different late left ventricular remodeling definitions for predicting long-term outcomes in acute myocardial infarction patients undergoing percutaneous coronary intervention. (14th October 2021) Authors: Zhang, S; Xie, X; He, C; Lin, X; Luo, M; Lin, M; Fang, M; You, Z; Lin, K; Guo, Y Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Evaluation of two classical contrast-induced nephropathy definitions for predicting long-term mortality in patients undergoing elective percutaneous coronary intervention. (25th November 2020) Authors: Lin, K; You, Z; Chen, H; He, C; Chen, X; Guo, Y; Zhu, P Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Extensible artificial intelligence model predicts post-ablation AF recurrence using coronary sinus electrogram. (25th November 2020) Authors: Huang, D; Zhang, Z; Lin, K; Zuo, Z; Chen, Q; Qian, D; Zhu, W; Li, J Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Imaging of cardiovascular complications in patients with systemic lupus erythematosus. (October 2015) Authors: Lin, K; Lloyd-Jones, D M; Li, D; Liu, Y; Yang, J; Markl, M; Carr, J C Journal: Lupus Issue: Volume 24:Number 11(2015) Page Start: 1126 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P.024 Long-term use of patisiran in patients with hereditary transthyretin amyloidosis (hATTR): 12 month efficacy & safety data from a global open label extension (OLE) study. (5th June 2019) Authors: Gonzalez-Duarte, A; Coelho, T; Adams, D; Yang, C; Polydefkis, M; Kristen, A; Tournev, I; Schmidt, H; Berk, J; Lin, K; Gandhi, PJ; Sweetser, M; White, M; Gollob, J; Suhr, OB Journal: Canadian journal of neurological sciences Issue: Volume 46(2019)Supplement 1 Page Start: S20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P.024 Long-term use of patisiran in patients with hereditary transthyretin amyloidosis (hATTR): 12 month efficacy & safety data from a global open label extension (OLE) study. (June 2019) Authors: Gonzalez-Duarte, A; Coelho, T; Adams, D; Yang, C; Polydefkis, M; Kristen, A; Tournev, I; Schmidt, H; Berk, J; Lin, K; Gandhi, PJ; Sweetser, M; White, M; Gollob, J; Suhr, OB Journal: Canadian journal of neurological sciences Issue: Volume 46(2019)Supplement 1 Page Start: S20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P.025 APOLLO, a phase 3 study of patisiran for the treatment of hereditary transthyretin amyloidosis (hATTR): 18-month safety and efficacy in subgroup with cardiac involvement. (5th June 2019) Authors: Vest, J; Solomon, S; Adams, D; Gonzalez-Duarte, A; O'Riordan, W; Yang, C; Coelho, T; Berk, J; Lin, K; Dyck, P; Gandhi, PJ; Sweetser, M; Suhr, OB; Kristen, A Journal: Canadian journal of neurological sciences Issue: Volume 46(2019)Supplement 1 Page Start: S20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P.025 APOLLO, a phase 3 study of patisiran for the treatment of hereditary transthyretin amyloidosis (hATTR): 18-month safety and efficacy in subgroup with cardiac involvement. (June 2019) Authors: Vest, J; Solomon, S; Adams, D; Gonzalez-Duarte, A; O'Riordan, W; Yang, C; Coelho, T; Berk, J; Lin, K; Dyck, P; Gandhi, PJ; Sweetser, M; Suhr, OB; Kristen, A Journal: Canadian journal of neurological sciences Issue: Volume 46(2019)Supplement 1 Page Start: S20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P535 COVID-19 vaccine-induced neutralising antibody responses against SARS-CoV-2 Omicron BA.4/5 are diminished in patients with inflammatory bowel disease on anti-TNF or JAK-inhibitor therapy. (30th January 2023) Authors: Liu, Z; Alexander, J; Le, K; Zhou, X; Ibraheim, H; Anandabaskaran, S; Saifuddin, A; Lin, K; Mcfarlane, L; Anand, N; Constable, L; Castro-Seoane, R; Nice, R; Bewshea, C; D'Mello, A; Jones, G R; Balarajah, S; Fiorentino, F; Sebastian, S; Irving, P Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i664 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗